19-58067056-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001289401.2(ZNF135):c.572G>A(p.Gly191Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,614,052 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001289401.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF135 | NM_001289401.2 | c.572G>A | p.Gly191Glu | missense_variant | 5/5 | ENST00000313434.10 | NP_001276330.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF135 | ENST00000313434.10 | c.572G>A | p.Gly191Glu | missense_variant | 5/5 | 1 | NM_001289401.2 | ENSP00000321406 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251298Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135838
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461874Hom.: 1 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 727238
GnomAD4 genome AF: 0.000112 AC: 17AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 17, 2023 | The c.644G>A (p.G215E) alteration is located in exon 4 (coding exon 4) of the ZNF135 gene. This alteration results from a G to A substitution at nucleotide position 644, causing the glycine (G) at amino acid position 215 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at